Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)

被引：0
|
作者：
Keisuke Miwa
Eiji Oki
Masanobu Enomoto
Keisuke Ihara
Koji Ando
Fumihiko Fujita
Masahiro Tominaga
Shinichiro Mori
Goro Nakayama
Mototsugu Shimokawa
Hiroshi Saeki
Hideo Baba
Masaki Mori
Yoshito Akagi
机构：
[1] Kurume University Hospital,Multidisciplinary Treatment Cancer Center
[2] Kyushu University,Department of Surgery and Science, Graduate School of Medical Sciences
[3] Tokyo Medical University,Gastrointestinal and Pediatric Surgery
[4] Dokkyo Medical University,First Department of Surgery
[5] Kurume University School of Medicine,Department of Surgery
[6] Department of Gastroenterological Surgery,Department of Digestive Surgery, Breast and Thyroid Surgery
[7] Hyogo Cancer Center,Department of Gastroenterological Surgery, Graduate School of Medicine
[8] Kagoshima University,Cancer Biostatistics Laboratory, Clinical Research Institute
[9] Nagoya University,Department of Biostatistics
[10] National Hospital Organization Kyusyu Cancer Center,Department of Gastroenterological Surgery
[11] Yamaguchi University Graduate School of Medicine,Department of Gastroenterological Surgery
[12] Gunma University Graduate School of Medicine,undefined
[13] Kumamoto University Graduate School of Medicine,undefined
来源：
BMC Cancer | / 21卷
关键词：
Rectal cancer; Neoadjuvant chemotherapy; Chemoradiotherapy; SOX; mFOLFOX6;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)
    Miwa, Keisuke
    Oki, Eiji
    Enomoto, Masanobu
    Ihara, Keisuke
    Ando, Koji
    Fujita, Fumihiko
    Tominaga, Masahiro
    Mori, Shinichiro
    Nakayama, Goro
    Shimokawa, Mototsugu
    Saeki, Hiroshi
    Baba, Hideo
    Mori, Masaki
    Akagi, Yoshito
    BMC CANCER, 2021, 21 (01)
  • [2] A randomized phase II study evaluating efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy for patients with resectable rectal cancer (KSCC1301).
    Katsumata, Kenji
    Oki, Eiji
    Kato, Hiroyuki
    Miwa, Keisuke
    Sugiyama, Masahiko
    Murakami, Hidetsugu
    Hasegawa, Hiroshi
    Mori, Shinichiro
    Nakayama, Goro
    Saeki, Hiroshi
    Shimokawa, Mototsugu
    Kakeji, Yoshihiro
    Baba, Hideo
    Akagi, Yoshito
    Maehara, Yoshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A Propensity Score Matching Analysis
    Ding, Miaomiao
    Zhang, Jianwei
    Hu, Huabin
    Cai, Yue
    Ling, Jiayu
    Wu, Zehua
    Xie, Xiaoyu
    Li, Jianxia
    Li, Weiwei
    Deng, Yanhong
    CLINICAL COLORECTAL CANCER, 2022, 21 (01) : E12 - E20
  • [4] A prospective, single-arm, multicenter trial of neoadjuvant chemotherapy with mFOLFOX6 plus panitumumab without radiotherapy for locally advanced rectal cancer
    Toritani, Kenichiro
    Watanabe, Jun
    Suwa, Yusuke
    Nakagawa, Kazuya
    Suwa, Hirokazu
    Ishibe, Atsushi
    Ota, Mitsuyoshi
    Kunisaki, Chikara
    Yamanaka, Takeharu
    Endo, Itaru
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2020, 35 (12) : 2197 - 2204
  • [5] A randomized phase II study comparing preoperative mFOLFOX6 versus FOLFOXIRI for locally advanced colon cancer: JCOG2006
    Hashimoto, Tadayoshi
    Maruyama, Satoshi
    Takii, Yasumasa
    Mizusawa, Junki
    Kataoka, Tomoko
    Fukuda, Haruhiko
    Tsukamoto, Shunsuke
    Takashima, Atsuo
    Hamaguchi, Tetsuya
    Kanemitsu, Yukihide
    Colorectal Canc Study Grp, Colorectal Canc Study Grp
    Japan Clinical Oncology Grp, Japan Clinical Oncology Grp
    FUTURE ONCOLOGY, 2023, 19 (28) : 1897 - 1904
  • [6] A prospective, single-arm, multicenter trial of neoadjuvant chemotherapy with mFOLFOX6 plus panitumumab without radiotherapy for locally advanced rectal cancer
    Kenichiro Toritani
    Jun Watanabe
    Yusuke Suwa
    Kazuya Nakagawa
    Hirokazu Suwa
    Atsushi Ishibe
    Mitsuyoshi Ota
    Chikara Kunisaki
    Takeharu Yamanaka
    Itaru Endo
    International Journal of Colorectal Disease, 2020, 35 : 2197 - 2204
  • [7] Totally neoadjuvant chemoradiation therapy with mFOLFOX6 in locally advanced rectal cancer: A single arm phase II study (FOTAC).
    Zhang, Jianwei
    Cai, Yue
    Hu, Huabin
    Xiao, Jian
    Chen, Dianke
    Ling, Jiayu
    Huang, Meijin
    Wang, Lei
    Kang, Liang
    Lan, Ping
    Wang, Jianping
    Deng, Yanhong
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [8] Feasibility and Efficacy of Neoadjuvant Chemotherapy without Radiotherapy for Locally Advanced Rectal Cancer
    Tokuhara, Katsuji
    Matsui, Yuki
    Ueyama, Yosuke
    Yoshioka, Kazuhiko
    Sekimoto, Mitsugu
    JOURNAL OF THE ANUS RECTUM AND COLON, 2022, 6 (01) : 24 - 31
  • [9] Totally neoadjuvant chemoradiation therapy with mFOLFOX6 in locally advanced rectal cancer: A single-arm phase II study (FOTAC).
    Deng, Yanhong
    Zhang, Jianwei
    Cai, Yue
    Hu, Huabin
    Xiao, Jian
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [10] A Multicenter Phase 2 Study on the Feasibility and Efficacy of Neoadjuvant Chemotherapy Without Radiotherapy for Locally Advanced Rectal Cancer
    Hasegawa, Suguru
    Goto, Saori
    Matsumoto, Takuya
    Hida, Koya
    Kawada, Kenji
    Matsusue, Ryo
    Yamaguchi, Takashi
    Nishitai, Ryuta
    Manaka, Dai
    Kato, Shigeru
    Kadokawa, Yoshio
    Yamanokuchi, Satoshi
    Kawamura, Junichiro
    Zaima, Masazumi
    Kyogoku, Takahisa
    Kanazawa, Akiyoshi
    Mori, Yukiko
    Kanai, Masashi
    Matsumoto, Shigemi
    Sakai, Yoshiharu
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (12) : 3587 - 3595
12345